Clinical trial Recruiting at 1 site Observational Ages 14 and up

Long-term safety follow-up after freezing nerves to help pain after chest surgery

Official title: Long Term Safety of Preoperative Percutaneous Intercostal Cryoneurolysis: Neuropathic Pain, Quality of Life and Sensory Recovery in a Paediatric Cohort Following Pectus Excavatum Repair

Run by Papa Giovanni XXIII Hospital · NCT07657845 · Data updated 2026-11-12

This study follow-ups patients who had percutaneous cryoneurolysis to help pain after Nuss procedure for pectus excavatum and checks their pain, nerve sensations, and quality of life over up to 24 months.

More Pectus Excavatum trials

Quick facts

Study typeObservational
Ages14 Years and up
SexAll
Enrollment50 (estimated)
SponsorPapa Giovanni XXIII Hospital
Academic / other
Locations1 site (Bergamo, BG)
StatusRecruiting
StartedFebruary 2, 2025
Main results expectedJune 13, 2026
Study endsJanuary 15, 2029
Registry record updatedJune 22, 2026
Trial IDNCT07657845 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 14 or older who had percutaneous cryoneurolysis in conjunction with Nuss procedure for pectus excavatum and are willing to complete follow-up visits and questionnaires.

Probably not a fit

Patients who do not experience neuropathic symptoms or chronic pain changes, or who miss follow-up visits, may not demonstrate a clear benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study tracks patients who received percutaneous cryoneurolysis for pain control after pectus excavatum repair with the Nuss procedure. Participants undergo physical exams and neurosensory assessments at 1, 3, 6, 12, and 24 months postoperatively, along with validated questionnaires to measure neuropathic and chronic pain and overall quality of life. Interventions include the LANSS questionnaire, the Pediatric Quality of Life Inventory (PedsQL), and a self-assessment sensory scale. The study aims to document long-term safety and patient-reported outcomes related to neuropathic symptoms, chronic pain, and life impact. Only patients who had the procedure and provide informed consent are eligible, with follow-up adherence as a key requirement.

Why it matters

Potential benefit: If successful, the study could clarify long-term safety and how sustained nerve freezing affects pain and quality of life after chest-wall surgery.

How similar studies have gone: Prior work in similar nerve-targeting pain interventions has shown mixed results; this study adds long-term observational data for this specific application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who underwent percutaneous cryoneurolysis.
* Patients who underwent surgical correction of pectus excavatum according to the Nuss procedure.
* Signed informed consent.

Exclusion Criteria:

* Refusal to participate in the study
* Peripheral nervous system disorders
* Age \< 14 years
* Failure to attend scheduled follow-up visits

Where it's running

  • ASST Papa Giovanni XXIII
    Bergamo, Bg, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.